Clinical Market Research Reports

This report provides an overview of the current market dynamics in the clinical manufacturing space and predictions for the next three years based on responses from people heavily involved in clinical manufacturing and the service provider selection process.

With this report, readers will better understand the experience of running decentralized trials, how service providers are perceived & used, and respondents' predictions for decentralized trials over the next few years.

For this report, 132 Phase II/III decision-makers were surveyed to share their insights into where the Phase II/III market is now and what changes they expect over the next several years.

This report will bring you and your company up to speed on available clinical logistics offerings and different types of service providers’ use patterns that can help you make informed decisions.

This report will help both study sponsors and providers answer a number of questions relevant to selecting and evaluating central lab service providers. For the purpose of this report, “central lab” is defined as a vendor that supplies specimen collection kits, logistics services, safety alerts, and a wide variety of laboratory testing services as well as providing lab reports to investigators.

This report gives quantitative insight into the perpetual question: “What is the size of the CRO market?” The data provide a thorough, rational perspective for clinical development services segmented by phase, geography, and service line.

For this report, ISR surveyed 109 respondents at sponsors and CROs regarding their experiences with hybrid trials and the providers of these services.

This market research report takes a look at user experiences with seven different clinical development outsourcing models.

This report takes a deep dive into two areas impacting the success of these studies: recruitment and retention. Given the importance of each rare disease patient, these activities are time-intensive and resource-heavy.

ISR surveyed 100 decision-makers in the pharmacovigilance space to get insight on their experience regarding how their companies’ pharmacovigilance activities are split between processes, how much of their work is outsourced, and both in-house and outsourced personnel locations.

This report includes verbatim insights into the practices that create clinical site start up efficiency, the causes of inefficiency, and new practices being undertaken in an effort to improve efficiency. To get multiple perspectives on the site start up process, ISR surveyed people with site start up responsibilities at sponsors and CROs as well as people working at clinical sites, such as clinical investigators and study coordinators.

Ask any HR manager working at a CRO or sponsor organization and they will tell you there is a war for talent when it comes to hiring and retaining high-quality CRAs. ISR decided to take a deep look at not only CRA salaries, but also signing bonuses, retention bonuses, raises, and turnover with the aim of benchmarking some industry trends. We collected data from 227 CRAs from various organizations and...

This report aims to assist small and emerging biopharma companies in selecting contract research organizations (CROs) by providing metrics and insights for informed decision-making. Additionally, it helps CROs optimize their strategies to better serve this segment through valuable customer insights and relevant information.

194 experienced Phase I outsourcers share insights from 613 recent service provider encounters. Sponsors and service providers can use this information to make the best decisions possible for their clinical development programs and service offerings.

This report informs sponsors and providers of the current and anticipated future market dynamics for outsourced bioanalytical lab activities and includes performance evaluations from over 300 customer encounters with 20+ service providers.

This report will give pharmaceutical companies and clinical logistics providers a comprehensive overview of outsourcing practices, in addition to a quantitative analysis of clinical logistics provider service quality across a series of 15 performance attributes specific to outsourced clinical logistics.

239 experienced Phase II/III outsourcers shared their insights regarding 846 recent service provider encounters. Sponsors and service providers can use this information to make the best decisions possible for their clinical development programs and service offerings.

This report can help small and emerging biopharma companies make more informed CRO selection decisions, and help CROs tailor their operational and marketing strategies to address the unique needs of up-and-coming drug innovators.

The goal of this market research report is to provide detailed information to aid in making informed decisions when outsourcing Phase IV work. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access...

This report aims to assist pharmaceutical sponsor organizations and CROs in making informed decisions when selecting electronic data capture (EDC) systems. It provides valuable insights into the provider selection process, including crucial criteria and factors that influence outsourcing decisions.

ISR surveyed 121 qualified CTMS decision makers to get their insights on the importance of various attributes in selecting a CTMS provider as well as their satisfaction with the performance of various CTMS providers against those same attributes.

This market research report covers the state of the IRT and its apparent transition from standalone point products to more fully integrated systems that use and feed data into other eClinical systems such as EDC systems, CTMS, and eCOA systems, in addition to managing randomization and drug supply functions.

Study sponsors and CROs can use this report for insight into user experience/satisfaction with leading eTMF software providers to inform their vendor selection process, and eTMF providers can use it to better understand their own strengths and weaknesses - and those of their competitors.

For this study, Industry Standard Research (ISR) collected both qualitative and quantitative data. Qualitative telephone interviews were used to gain insight into mHealth expert viewpoints, while a quantitative, internet-based survey was used to collect hard data on familiarity with mHealth, anticipated implementation, and usage rates in recent or soon-to-be conducted clinical trials.

Technology forges a world where human connection is no longer inhibited by distance. Barriers are broken and replaced with virtual bridges that create unprecedented potential for an interconnected present and future. And no doubt the areas most affected by this technological nexus are ones dominated by human synergy. An area at...

This report provides an in-depth exploration of the role and function of Chemistry, Manufacturing, and Controls (CMC) throughout the stages of product development, spanning preclinical, clinical, and commercialization phases. A specific emphasis is placed on the configuration of the CMC function within virtual and small biopharmaceutical companies.

This report uncovers the unique benefits and drawbacks of three outsourcing models commonly used in the clinical trial space. In addition, survey respondents provided insight into their use of in-house and in-sourced resources, strategic partners, and preferred providers.

ISR conducted 11 in-depth interviews with tenured post-marketing safety and pharmacovigilance professionals from leading biotechnology and pharmaceutical companies in North America and Europe.

For this report, ISR conducted interviews with a cross-section of executive, director, and managerial level MM professionals from large, mid-size, and small pharmaceutical and biotech companies to gain a better understanding of managed markets departments, how they work, and the challenges they face.

This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...